| Autor: |
Smieszek, Sandra P., Kaden, Alyssa R., Johnson, Caroline E., Brzezynski, Jennifer L., Xiao, Changfu, Polymeropoulos, Christos M., Birznieks, Gunther, Emsellem, Helene A., Polymeropoulos, Mihael H. |
| Předmět: |
|
| Zdroj: |
Frontiers in Neuroscience; 2023, p01-05, 5p |
| Abstrakt: |
We present a case of an adult female diagnosed with Delayed Sleep-Wake Phase Disorder (DSWPD) and Optic Nerve Hypoplasia (ONH), with a confirmed delayed Dim Light Melatonin Onset (DLMO), who reports the inability to fall asleep at their desired bedtime and obtain adequate sleep nightly, despite the ability to have a full night's sleep when not required to be up at a specific time for societal requirements. The participant was enrolled in an 11-month Open-Label Extension (OLE) following the randomized portion of a clinical study and was successfully treated with tasimelteon. DSWPD symptoms were resolved, and their previously delayed sleep-wake cycle was advanced. Clinical trial registration: https://clinicaltrials.gov/ct2/show/NCT04652882, identifier NCT04652882. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
